Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is often linked to other health issues like allergies, thyroid problems, and diabetes.

Insulin therapy helped a man with autoimmune issues regrow his hair.

Trichothiodystrophy is a rare genetic disorder causing hair issues and sometimes linked to DNA repair defects.

A 45-year-old woman with autoimmune diseases experienced patchy hair loss due to alopecia areata, which has no cure but can be treated, with varying success.

Trichohyalin may trigger the immune response causing alopecia areata.

Plaque-type herpetic folliculitis affects eccrine glands.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Alopecia areata patients have a higher risk of other immune-related diseases.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

Ayurvedic treatments may help reduce hypothyroidism symptoms.

Anti-TNF therapy can cause a rare hair loss condition similar to alopecia areata.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.

A 90-year-old man was diagnosed with heart failure due to wild-type transthyretin cardiac amyloidosis.

Ayme-Gripp Syndrome was confirmed in a woman through genetic testing, highlighting the need to consider rare genetic conditions in diagnoses.

Blocking interferon-gamma might help treat various autoimmune diseases.

Both atopy and eosinophilia are linked to more severe hair loss in people with alopecia areata.

Treatments for autoimmune hair loss have limited success and patients need emotional support and self-acceptance.

Telogen effluvium is a common hair loss condition requiring careful diagnosis and treatment.

BST2 is highly expressed in certain immune cells in alopecia areata, suggesting a role in the disease.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

Allergen-specific immunotherapy can significantly improve hair loss and dermatitis symptoms in severe cases.

Thyroid-stimulating hormone affects hair follicles but doesn't change hair growth or color.

Topical immunotherapy can help with severe hair loss, but results vary and need personalized, long-term treatment.

Intralesional cidofovir might be a viable alternative treatment for certain conditions.

Patients with alopecia areata should be checked for muscle spasms, diarrhea, and ANA to avoid missing Satoyoshi syndrome.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.